NASDAQ:ICAD iCAD (ICAD) Stock Price, News & Analysis $3.48 -0.02 (-0.57%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$3.58 +0.10 (+2.84%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About iCAD Stock (NASDAQ:ICAD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get iCAD alerts:Sign Up Key Stats Today's Range$3.45▼$3.5650-Day Range$1.66▼$3.5052-Week Range$1.18▼$3.78Volume345,204 shsAverage Volume382,758 shsMarket Capitalization$95.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company OverviewiCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.Read More… iCAD Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreICAD MarketRank™: iCAD scored higher than 12% of companies evaluated by MarketBeat, and ranked 630th out of 654 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for iCAD.Read more about iCAD's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of iCAD is -26.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iCAD is -26.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiCAD has a P/B Ratio of 2.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about iCAD's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.04% of the float of iCAD has been sold short.Short Interest Ratio / Days to CoveriCAD has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iCAD has recently decreased by 0.41%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiCAD does not currently pay a dividend.Dividend GrowthiCAD does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.04% of the float of iCAD has been sold short.Short Interest Ratio / Days to CoveriCAD has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iCAD has recently decreased by 0.41%, indicating that investor sentiment is improving. News and Social Media2.1 / 5News Sentiment0.77 News SentimentiCAD has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 7 news articles for iCAD this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for ICAD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iCAD insiders have not sold or bought any company stock.Percentage Held by Insiders10.29% of the stock of iCAD is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.61% of the stock of iCAD is held by institutions.Read more about iCAD's insider trading history. Receive ICAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iCAD and its competitors with MarketBeat's FREE daily newsletter. Email Address ICAD Stock News HeadlinesClinical AI Platforms Expand Globally Amid Regulatory and Market TailwindsMay 1, 2025 | tmcnet.comiCAD and Microsoft join forces for AI mammography solutionsApril 30, 2025 | finance.yahoo.comOur $1 AI stock to buy right nowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so. Musk has been quietly creating one of the most ambitious AI ventures in history.May 6, 2025 | Behind the Markets (Ad)Equity Insider: Clinical AI Platforms Expand Globally Amid Regulatory and Market TailwindsApril 29, 2025 | finanznachrichten.deiCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)April 29, 2025 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, WBA, RDW on Behalf of ShareholdersApril 24, 2025 | morningstar.com3 Promising Penny Stocks With Market Caps Under $200MApril 17, 2025 | finance.yahoo.comLaidlaw & Co. Downgrades iCAD (ICAD)April 17, 2025 | msn.comSee More Headlines ICAD Stock Analysis - Frequently Asked Questions How have ICAD shares performed this year? iCAD's stock was trading at $1.83 at the beginning of 2025. Since then, ICAD shares have increased by 90.2% and is now trading at $3.48. View the best growth stocks for 2025 here. How were iCAD's earnings last quarter? iCAD, Inc. (NASDAQ:ICAD) announced its earnings results on Wednesday, March, 19th. The technology company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.02. The technology company earned $5.41 million during the quarter, compared to analysts' expectations of $4.72 million. iCAD had a negative trailing twelve-month return on equity of 15.65% and a negative net margin of 17.81%. Read the conference call transcript. Who are iCAD's major shareholders? iCAD's top institutional investors include Summit Trail Advisors LLC (0.27%), Salem Investment Counselors Inc. (0.12%) and Greenwood Capital Associates LLC (0.10%). Insiders that own company stock include Jonathan Go and Dana R Brown. View institutional ownership trends. How do I buy shares of iCAD? Shares of ICAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iCAD own? Based on aggregate information from My MarketBeat watchlists, some other companies that iCAD investors own include Enovix (ENVX), Globant (GLOB), Rambus (RMBS), Luminar Technologies (LAZR), Toast (TOST), COMPASS Pathways (CMPS) and Ginkgo Bioworks (DNA). Company Calendar Last Earnings3/19/2025Today5/06/2025Next Earnings (Estimated)5/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:ICAD CIK749660 Webwww.icadmed.com Phone(603) 882-5200Fax603-880-3843Employees140Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,850,000.00 Net Margins-17.81% Pretax Margin-27.87% Return on Equity-15.65% Return on Assets-12.52% Debt Debt-to-Equity RatioN/A Current Ratio4.02 Quick Ratio3.91 Sales & Book Value Annual Sales$19.61 million Price / Sales4.86 Cash FlowN/A Price / Cash FlowN/A Book Value$1.27 per share Price / Book2.74Miscellaneous Outstanding Shares27,366,000Free Float23,809,000Market Cap$95.23 million OptionableOptionable Beta1.78 Social Links 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NASDAQ:ICAD) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iCAD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iCAD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.